On-the-spot drug checking for xylazine in Minnesota
Community Mitigation Against Xylazine
['FUNDING_R21'] · RESEARCH TRIANGLE INSTITUTE · NIH-11174485
This program offers on-the-spot testing of street drugs for xylazine to people who use drugs and the programs that serve them in Minnesota.
Quick facts
| Phase | ['FUNDING_R21'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | RESEARCH TRIANGLE INSTITUTE (nih funded) |
| Locations | 1 site (RESEARCH TRIANGLE PARK, UNITED STATES) |
| Trial ID | NIH-11174485 on ClinicalTrials.gov |
What this research studies
You would be offered drug checking through local overdose prevention programs that use portable machines and xylazine test strips to see if a sample contains xylazine. The program will collect information about the local drug supply and provide wound care kits, referrals to treatment, and harm-reduction advice at the time of testing. Mobile outreach will bring services to smaller towns as well as cities, and staff will ask clients what works and what could be improved. The goal is to give real-time information so people can make safer choices and get help quickly.
Who could benefit from this research
Good fit: Ideal participants are people who use or handle illicit drugs and clients of overdose prevention programs in Minnesota, including those in rural and urban areas.
Not a fit: People who do not use illicit drugs or who live outside Minnesota are unlikely to benefit directly from this program.
Why it matters
Potential benefit: If successful, this could give people timely warnings about dangerous xylazine in the drug supply and connect them to wound care and treatment services.
How similar studies have performed: Drug checking programs using FTIR and test strips have detected dangerous adulterants in some cities, but their use in less populated areas and specifically for xylazine is less well studied.
Where this research is happening
RESEARCH TRIANGLE PARK, UNITED STATES
- RESEARCH TRIANGLE INSTITUTE — RESEARCH TRIANGLE PARK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: RAY, BRADLEY — RESEARCH TRIANGLE INSTITUTE
- Study coordinator: RAY, BRADLEY
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.